Veradermics, Incorporated (MANE) — Financial Flexibility Index

Latest as of March 2026: -3.15x

Veradermics, Incorporated (MANE) has a Financial Flexibility Index of -3.15x as of March 2026. Free cash flow of $-21.17 Million (operating CF $-21.17 Million minus capex $0.00) represents -3% of total liabilities ($6.72 Million). Also explore net asset momentum of Veradermics, Incorporated to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-3.15x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-21.17 Million
Operating CF − Capex

Total Liabilities

$6.72 Million
USD

Capital Expenditures

$0.00
USD

Veradermics, Incorporated Financial Flexibility Index (2023–2025)

Historical Financial Flexibility Index trend for Veradermics, Incorporated across 3 annual periods. Check asset resilience ratio of Veradermics, Incorporated to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Veradermics, Incorporated (2023–2025)

Year-by-year free cash flow to debt coverage for Veradermics, Incorporated. For the full company profile including market capitalisation, see MANE market cap overview.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.26x $-71.58 Million $-71.60 Million $273.63 Million ▲ +94.8%
2024 -5.02x $-23.69 Million $-23.69 Million $4.72 Million ▼ -42.6%
2023 -3.52x $-13.51 Million $-13.51 Million $3.84 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities